AMAG Pharmaceuticals Inc (AMAG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AMAG Pharmaceuticals Inc (AMAG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7208
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AMAG Pharmaceuticals Inc (AMAG) develops and commercializes specialty pharmaceutical products with focus on maternal health, anemia management and cancer supportive care. It develops and markets products used to reduce the risk of preterm birth in women with a single baby who have a history of singleton spontaneous preterm birth; and products for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron and chronic kidney diseases. AMAG also provides services related to the collection, processing and storage of umbilical cord blood stem cell and cord tissue units. The company offers its products through a direct sales force and a network of distributors. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc (AMAG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AMAG Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AMAG Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Private Equity 10
GI Partners Acquires CBR Systems from AMAG Pharma for USD530 Million 10
Access Pharma Enters Into Licensing Agreement With Amag Pharma For MuGard 12
Equity Offering 13
AMAG Pharma Raises USD230.9 Million in Public Offering of Shares 13
Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To US$250 Million 15
Debt Offering 16
AMAG Pharma Prices Public Offering of 3.25% Notes Due 2022 for USD300 Million 16
AMAG Pharma Raises USD500 Million in Private Placement of 7.878% Notes Due 2023 18
Amag Pharma Completes Public Offering Of Notes Due 2019 For US$200 Million 19
AMAG Pharmaceuticals Inc – Key Competitors 21
AMAG Pharmaceuticals Inc – Key Employees 22
AMAG Pharmaceuticals Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 02, 2018: AMAG Pharmaceuticals announces second quarter 2018 financial results and provides corporate update 24
May 03, 2018: AMAG Pharmaceuticals Announces First Quarter 2018 Financial Results and Raises Full Year Financial Guidance 26
Feb 27, 2018: AMAG Reports 2017 Financial Results and Company Update 28
Jan 08, 2018: AMAG Pharmaceuticals Announces Preliminary 2017 Financial Results and Provides 2018 Guidance 30
Nov 02, 2017: AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights 32
Aug 03, 2017: AMAG Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update 35
May 02, 2017: AMAG Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update 39
Feb 14, 2017: AMAG Reports Fourth Quarter and Full Year 2016 Financial Results 41
Jan 09, 2017: AMAG Pharmaceuticals Provides Financial and Business Update 44
Corporate Communications 46
Aug 06, 2018: AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs 46
May 02, 2018: AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer 47
Aug 08, 2017: AMAG Pharmaceuticals Appoints Oscar Sanchez as Vice President of Quality 48
May 16, 2017: AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of Regulatory Affairs 49
Apr 25, 2017: AMAG Pharmaceuticals Appoints Arpad Simon, M.D. as Vice President of Pharmacovigilance 50
Mar 06, 2017: AMAG Announces Management Changes and New Commercial Appointments 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
AMAG Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AMAG Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AMAG Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
AMAG Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GI Partners Acquires CBR Systems from AMAG Pharma for USD530 Million 10
Access Pharma Enters Into Licensing Agreement With Amag Pharma For MuGard 12
AMAG Pharma Raises USD230.9 Million in Public Offering of Shares 13
Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To US$250 Million 15
AMAG Pharma Prices Public Offering of 3.25% Notes Due 2022 for USD300 Million 16
AMAG Pharma Raises USD500 Million in Private Placement of 7.878% Notes Due 2023 18
Amag Pharma Completes Public Offering Of Notes Due 2019 For US$200 Million 19
AMAG Pharmaceuticals Inc, Key Competitors 21
AMAG Pharmaceuticals Inc, Key Employees 22
AMAG Pharmaceuticals Inc, Other Locations 23
AMAG Pharmaceuticals Inc, Subsidiaries 23

List of Figures
AMAG Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AMAG Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AMAG Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AMAG Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AMAG Pharmaceuticals Inc (AMAG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GC Pharma (006280):製薬・医療:M&Aディール及び事業提携情報
    Summary GC Pharma(GC Pharma) formerly known as Green Cross Corp, a subsidiary of Green Cross Holdings Corp provides plasma protein therapeutics and vaccines. The company develops, manufactures and markets a wide product portfolio comprising plasma derivatives including albumin, immunoglobulin, and a …
  • Sumitomo Heavy Industries Construction Cranes Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Heavy Industries Construction Cranes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • BELLUS Health Inc (BLU)-製薬・医療分野:企業M&A・提携分析
    Summary BELLUS Health Inc (BELLUS Health) is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company’s pipeline products include BLU-5937 for chronic cough, Shigamab for STEC related hemolytic syndrome (sHUS); KIACTA for the treatment of a second ind …
  • Aceto Corp (ACET):企業の財務・戦略的SWOT分析
    Aceto Corp (ACET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hanwei Energy Services Corp (HE):企業の財務・戦略的SWOT分析
    Summary Hanwei Energy Services Corp (Hanwei Energy) is a chemical company that develops, manufactures and distributes plastic fibre reinforced piping systems. The company’s products include anhydride and amine cured frp pipes, fittings, fixtures and flanges. It offers client solutions such as pre-te …
  • Dine Brands Global, Inc. (DIN):企業の財務・戦略的SWOT分析
    Dine Brands Global, Inc. (DIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Efore Oyj (EFO1V):企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aleva Neurotherapeutics SA:医療機器:M&Aディール及び事業提携情報
    Summary Aleva Neurotherapeutics SA (Aleva) is a medical device company that provides neuro-stimulation solutions. The company’s products include deep brain stimulation diagnostic systems and deep brain stimulation systems. Its deep brain stimulation systems provide directional stimulation for more p …
  • Foster Poultry Farms, Inc.:企業の戦略的SWOT分析
    Foster Poultry Farms, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Protalix BioTherapeutics Inc (PLX):企業の財務・戦略的SWOT分析
    Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • MEG Energy Corp (MEG):企業の財務・戦略的SWOT分析
    MEG Energy Corp (MEG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fraser & Neave Holdings Bhd:戦略・SWOT・企業財務分析
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Konka Group Co., Ltd.:企業の戦略・SWOT・財務分析
    Konka Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Konka Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hydrogenics Corporation (HYG):電力:M&Aディール及び事業提携情報
    Summary Hydrogenics Corporation (Hydrogenics) is a provider of power generation equipment. The company designs, develops, and manufactures hydrogen generation and fuel cell products. It produces products on water electrolysis and proton exchange membrane technologies. Hydrogenics also provides vario …
  • SYNNEX Corporation:企業の戦略・SWOT・財務情報
    SYNNEX Corporation - Strategy, SWOT and Corporate Finance Report Summary SYNNEX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • North China Pharmaceutical Co Ltd (600812):製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Co Ltd (NCPC), a subsidiary of North China Pharmaceutical Group Corp is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company offers preparation products, nutrition, pharmaceutical raw materials and …
  • HORNBACH Holding AG & Co. KGaA:企業の戦略・SWOT・財務分析
    HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Navitor Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Navitor Pharmaceuticals Inc (Navitor Pharmaceuticals) is a biopharmaceutical company that develops medicines by targeting cellular nutrient signaling pathways. The company harnesses its proprietary drug discovery platform to develop selective modulators of the mTORC1 pathway. It develops mTO …
  • OPG Power Ventures Plc (OPG):電力:M&Aディール及び事業提携情報
    Summary OPG Power Ventures Plc (OPG) is an electric utility. It develops, owns, operates, and maintains private sector power projects in India. The company produces electricity from coal source. OPG operates coal-fired power plants in Tamil Nadu and Gujarat. It sells the electricity generated from i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆